29 related articles for article (PubMed ID: 631965)
1. Long-term use of propranolol, ibuprofen, and spironolactone in the management of Bartter's syndrome.
Cunningham RJ; Brouhard BH; Berger M; Petrusick T; Travis LB
Pediatrics; 1979 May; 63(5):754-6. PubMed ID: 440896
[TBL] [Abstract][Full Text] [Related]
2. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
Favre L; Glasson P; Flory ED; Dray F; Vallotton MB
Schweiz Med Wochenschr; 1979 Feb; 109(5):142-7. PubMed ID: 441720
[TBL] [Abstract][Full Text] [Related]
3. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
Horký K; Schreiber V; Dvoráková J
Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182
[TBL] [Abstract][Full Text] [Related]
4. Escape from sodium and potassium retaining actions of aspirin-like drugs used in a patient with Bartter's syndrome.
Ishikawa Y; Wada T
Jpn Circ J; 1979 Aug; 43(8):757-67. PubMed ID: 501898
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic studies in Bartter's syndrome: effect of DDAVP and indomethacin on renal concentrating operation. Part II.
Radó JP; Simatupang T; Boer P; Dorhout Mees EJ
Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):22-6. PubMed ID: 631967
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic studies in Bartter's syndrome: opposite effects of treatment with antikaliuretic and antiprostaglandin drugs. Part I.
Simatupang TA; Radó JP; Boer P; Geyskes GG; Vos J; Dorhout Mees EJ
Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):14-8. PubMed ID: 631965
[TBL] [Abstract][Full Text] [Related]
7. Bartter's syndrome.
Bartter FC
Urol Clin North Am; 1977 Jun; 4(2):253-61. PubMed ID: 331616
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandins, potassium, and Bartter's syndrome.
Ferris TF
J Lab Clin Med; 1978 Nov; 92(5):663-8. PubMed ID: 361914
[No Abstract] [Full Text] [Related]
9. Role of prostaglandins in the pathogenesis of Bartter's syndrome.
Fichman MP; Telfer N; Zia P; Speckart P; Golub M; Rude R
Am J Med; 1976 May; 60(6):785-97. PubMed ID: 798488
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous derangement of cellular sodium metabolism in Bartter's syndrome. Description of two cases and review of the literature.
Sechi LA; Melis A; Faedda R; Tedde R; Bartoli E
Panminerva Med; 1992; 34(2):85-92. PubMed ID: 1408334
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandins and Bartter's syndrome.
Dunn MJ
Kidney Int; 1981 Jan; 19(1):86-102. PubMed ID: 7012423
[No Abstract] [Full Text] [Related]
12. Suppressed diluting segment reabsorption in Bartter's syndrome: studies in 1 patient and synthesis of literature data.
Hené RJ; Koomans HA; Mees EJ
Am J Nephrol; 1988; 8(5):402-9. PubMed ID: 3071147
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
